Donor serum smarcal1 concentrations predict primary graft dysfunction in cardiac transplantation

Circulation

Volumn 120, Issue SUPPL. 1, 2009, Pages

  Aharinejad, Seyedhossein ^a,b,c   Andrukhova, Olena ^b,c   Gmeiner, Matthias ^a,c   Thomas, Anita ^b,c   Aliabadi, Arezu ^a,c   Zuckermann, Andreas ^a,c   Krenn, Katharina ^c   Grimm, Michael ^a,b,c  

^a Department of Cardiothoracic Surgery ^*  (Austria)

^b Center for Anatomy and Cell Biology   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cardiac transplantation; Marker; Primary graft dysfunction; SMARCAL1

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HELICASE; PROTEIN SMARCAL1; REGULATOR PROTEIN; UNCLASSIFIED DRUG; MESSENGER RNA; SMARCAL1 PROTEIN, HUMAN;

ADULT; AGED; AORTA CLAMPING; ARTICLE; ASSISTED CIRCULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT DYSFUNCTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OXYGEN SATURATION; PREDICTION; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; BLOOD; DONOR; GENETICS; HEART MUSCLE; METABOLISM; MIDDLE AGED; MORTALITY; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGED; DNA HELICASES; FEMALE; HEART TRANSPLANTATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIUM; PRIMARY GRAFT DYSFUNCTION; RNA, MESSENGER; SURVIVAL RATE; TISSUE DONORS;

EID: 70349784287     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.842971     Document Type: Article

References (27)

1. 1. Taylor DO, Edwards LB, Bouček MM, Trulock EP, Deng MC, Keck BM, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report. J Heart Lung Transplant. 2005;24:945-955. (Pubitemid 41127174)
2. 2. Jahania MS, Mullett TW, Sanchez JA, Narayan P, Lasley RD, Mentzer RM Jr. Acute allograft failure in thoracic organ transplantation. J Card Surg. 2000;15:122-128. (Pubitemid 32434297)
3. 3. Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. Circulation. 2006;114:127-132. (Pubitemid 44297124)
4. Rodeheffer RJ, Naftel DC, Stevenson LW, Porter CB, Young JB, Miller LW, Kenzora JL, Haas GJ, Kirklin JK, Bourge RC. Secular trends in. cardiac transplant recipient and donor management in the United States, 1990 to 1994. A multi-institutional study. Cardiac Transplant Research Database Group. Circulation. 1996;94:2883-2889.
5. Costanzo MR, Augustine S, Bourge R, Bristow M, O'Connell JB, Driscoll D, Rose E. Selection, and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92: 3593-3612.
6. Suzuki K, Murtuza B, Smolenski RT, Sammut IA, Suzuki N, Kaneda Y, Yacoub MH. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation. 2001;104:1308-1313.
7. 7. Szabó G, Stumpf N, Radovits T, Sonnenberg K, Gero D, Hagl S, Szabó C, Bährle S. Effects of inosine on reperfusion injury after heart transplantation. Eur J Cardiothorac Surg. 2006;30:96-102. (Pubitemid 43850335)
8. 8. Aharinejad S, Schäfer R, Krenn K, Zuckermann A, Schneider B, Neumann F, Paulus P, Wieselthaler G, Wolner E, Grimm M. Donor myocardial HIF-1α is an independent predictor of cardiac allograft dysfunction: a 7-year prospective, exploratory study. Am J Transplant. 2007; 7:2012-2019. (Pubitemid 47037985)
9. Yusufzai T, Kadonaga JT. HARP is an ATP-driven annealing helicase. Science. 2008;322:748-750.
10. 10. Aharinejad S, Krenn K, Paulus P, Schäfer R, Zuckermann A, Grimm M, Abraham. D. Differential role of TGF-beta1/bFGF and ET-1 in graft fibrosis in heart failure patients. Am. J Transplant. 2005;5:2185-2192. (Pubitemid 41648465)
11. 11. Marasco SF, Esmore DS, Negri J, Rowland M, Newcomb A, Rosenfeldt FL, Bailey M, Richardson M. Early institution, of mechanical support improves outcomes in primary cardiac allograft failure. J Heart Lung Transplant. 2005;24:2037-2042. (Pubitemid 41814721)
12. 12. Taghavi S, Zuckermann A, Ankersmit J, Wieselthaler G, Rajek A, Laufer G, Wolner E, Grimm M. Extracorporeal membrane oxygenation is superior to right ventricular assist device for acute right ventricular failure after heart transplantation. Ann Thorac Surg. 2004;78:1644-1649. (Pubitemid 39423530)
13. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
14. 14. Wang CY, Naka Y, Liao H, Oz MC, Springer TA, Gutierrez-Ramos JC, Pinsky DJ. Cardiac graft intercellular adhesion molecule-1 (ICAM-I) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-I in organs remote from, the site of transplantation. Circ Res. 1998;82:762-772. (Pubitemid 28185843)
15. 15. Plenz G, Eschert H, Erren. M, Wichter T, Böhm M, Flesch M, Scheid HH, Deng MC. The interleukin-6/interleukin-6-receptor system, is activated in donor hearts. J Am Coll. Cardiol. 2002;39:1508-1512. (Pubitemid 34439068)
16. 16. Birks EJ, Owen VJ, Burton PB, Bishop AE, Banner NR, Khaghani A, Polak JM, Yacoub MH. Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. Circulation. 2000;102:326-331. (Pubitemid 30457584)
17. Taylor DO, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Rahmel AO, Kucheryavaya AY, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant. 2008;27:943-956.
18. 18. Marelli D, Laks H, Patel B, Kermani R, Marmureanu A, Patel J, Kobashigawa J. Heart transplantation in patients with diabetes mellitus in the current era. J Heart Lung Transplant. 2003;22:1091-1097. (Pubitemid 37206564)
19. 19. Tsai FC, Marelli D, Bresson J, Gjertson D, Kermani R, Ardehali A, Esmailian F, Hamilton M, Fonarow GC, Moriguchi J, Plunkett M, Hage A, Tran J, Kobashigawa JA, Laks H. Recent trends in early outcome of adult patients after heart transplantation: a single-institution review of 251 transplants using standard donor organs. Am J Transplant. 2002;2: 539-545. (Pubitemid 36306873)
20. Oto T, Excell L, Griffiths AP, Levvey BJ, Bailey M, Marasco S, Macdonald P, Snell GI. Association between primary graft dysfunction among lung, kidney and heart recipients from, the same multiorgan donor. Am J Transplant. 2008;8:2132-2139.
21. 21. Segovia J, Pulpón LA, Sanmartín M, Tejero C, Serrano S, Burgos R, Castedo E, Ugarte J. Primary graft failure in heart transplantation: a multivariate analysis. Transplant Proc. 1998;30:1932. (Pubitemid 28399376)
22. 22. Stern. M, Jensen. R, Herskowitz I. Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol. 1984;178:853-868. (Pubitemid 16223334)
23. Pazin MJ, Kadonaga JT. SWI2/SNF2 and related proteins: ATP-driven motors that disrupt protein-DNA interactions? Cell. 1997;88:737-740.
24. 24. Zofall M, Persinger J, Kassabov SR, Bartholomew B. Chromatin remodeling by ISW2 and SWI/SNF requires DNA translocation inside the nucleosome. Nat Struct Mol Biol. 2006;13:339-346. (Pubitemid 43873505)
25. Kadam S, Emerson BM. Mechanisms of chromatin, assembly and transcription. Curr Opin Cell Biol. 2002;14:262-268.
26. Huang C, Sloan EA, Boerkoel CF. Chromatin remodeling and disease. Curr Opin Genetics Develop. 2003;13:246-252.
27. Wittwer T, Wahlers T. Marginal donor grafts in heart transplantation: lessons learned from 25 years of experience. Transpl Int. 2008;21: 113-125.